US Broker Ratings

Belite Bio, Inc (BLTE) Stock Analysis: A Glimpse into the Biotech’s 3.43% Potential Upside

Belite Bio, Inc (BLTE), a burgeoning name in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling retinal degenerative diseases. With a market capitalization..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 48.59% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a burgeoning player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, is capturing investor interest with a compelling potential upside of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating the Healthcare Sector with a 2.30% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a noteworthy name in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.92 billion, Tandem is a..

NovoCure Limited (NVCR) Investor Outlook: Exploring a Potential 129.64% Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with its oncology-focused innovations and a significant potential upside of 129.64%. Specializing in the..

Dyne Therapeutics (DYN) Stock Analysis: Exploring a 153% Potential Upside in the Biotech Arena

Investors seeking opportunities in the biotechnology sector should take a closer look at Dyne Therapeutics, Inc. (NASDAQ: DYN), a promising clinical-stage company focused on developing therapeutics for neuromuscular diseases. Despite..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 109.83% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an innovative player in the biotechnology sector, is making waves with its regenerative medicine products. Headquartered in Melbourne, Australia, the company is pushing the boundaries of..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential Offers an Attractive Opportunity

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment proposition. With a market capitalization of $1.39 billion, the company stands..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Evaluating a Potential 105% Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology industry with its robust integration of technology and biology aimed at revolutionizing drug discovery. With a current market capitalization..

Immunocore Holdings plc (IMCR) Stock Analysis: Significant Upside Potential with a 102% Gain on the Horizon

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with its innovative approach to developing immunotherapies for cancer, infectious, and autoimmune diseases. With a market capitalization of $1.66..

ICU Medical, Inc. (ICUI) Stock Analysis: Investors Eye 20% Upside Potential Amid Healthcare Sector Dynamics

ICU Medical, Inc. (NASDAQ: ICUI) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in San Clemente, California, ICU Medical has..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating Growth in Rare Diseases with Strong Revenue Momentum

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stands at the forefront of the biotechnology sector, leveraging its innovative approach to develop treatments for rare diseases. With a market capitalization of $4.5 billion,..

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Robotics Sector

SS Innovations International, Inc. (OTC: SSII) is carving a niche in the burgeoning healthcare sector, specifically in medical devices, with its innovative approach to surgical robotics. Headquartered in Gurugram, India,..

Clover Health Investments (CLOV) Stock Analysis: A Potential 64% Upside for Investors

Clover Health Investments, Corp. (NASDAQ: CLOV) is capturing the attention of investors with a compelling mix of challenges and opportunities. Operating within the dynamic healthcare sector, this company is carving..

Dynavax Technologies Corporation (DVAX) Investor Outlook: A Glimpse into Its 3.23% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, is garnering attention for its innovative approach to vaccine development. With a market capitalization of $1.82 billion, this..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 72.55% Potential Upside in Biotech

MannKind Corporation (NASDAQ: MNKD) offers an intriguing prospect for investors searching for opportunities in the biotech sector. With a market capitalization of $1.71 billion, MannKind stands out as a healthcare..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: A 169% Upside Potential Sparks Interest

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands at a pivotal juncture in the biotech sector, capturing investor attention with a remarkable 169% potential upside, as projected by analysts. With its focus..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a Potential 95.87% Upside in a Challenging Landscape

Teladoc Health, Inc. (NYSE: TDOC), a healthcare industry disruptor, is at a pivotal moment for investors, with a potential upside of 95.87% as analysts weigh in on its prospects. As..

Indivior Pharmaceuticals, Inc. (INDV) Investor Outlook: Strong Buy Ratings and 38% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) is garnering significant attention in the healthcare sector, particularly among investors focused on the drug manufacturers specializing in opioid dependence treatments. With a market capitalization..

Addus HomeCare Corporation (ADUS) Stock Analysis: Promising 19.87% Upside with Strong Buy Ratings

Addus HomeCare Corporation (NASDAQ: ADUS), a notable player in the healthcare sector, operates within the medical care facilities industry and has been capturing investor attention with its compelling growth metrics..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 45% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Progyny, Inc. (NASDAQ: PGNY) presents an intriguing prospect. Headquartered in New York, Progyny specializes in fertility and family-building benefits solutions, offering personalized..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds